Amgen still sees pandemic impact, with fewer patients starting treatments

Amgen Inc. stock fell in the extended session Tuesday after the pharma company reported rising adjusted profit for the third quarter but said the pandemic-related gap in doctor's office visits and fewer people starting treatments continue to impact its business.